AdaptHealth (AHCO) Set to Post Earnings on Tuesday

AdaptHealth (NASDAQ:AHCO) is expected to announce its Q3 2026 results before the market opens on Tuesday, November 3rd. Analysts expect the company to post earnings of ($0.0505) per share and revenue of $725.87 million for the quarter. Individuals can find conference call details on the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 8:30 AM ET.

AdaptHealth (NASDAQ:AHCO) last posted its quarterly earnings data on Tuesday, August 4th. The company reported ($0.99) earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($1.16). The firm had revenue of $740.31 million during the quarter, compared to analyst estimates of $846.77 million. AdaptHealth had a negative net margin of 7.07% and a positive return on equity of 3.36%. The business’s quarterly revenue was down 7.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.10 EPS.

AdaptHealth Stock Performance

Shares of AHCO opened at $5.93 on Tuesday. The company has a debt-to-equity ratio of 1.37, a quick ratio of 0.98 and a current ratio of 1.12. The company has a market capitalization of $808.52 million, a price-to-earnings ratio of -3.47 and a beta of 1.42. The company’s 50 day simple moving average is $5.86 and its 200 day simple moving average is $9.28. AdaptHealth has a 1 year low of $5.21 and a 1 year high of $13.43.

Insider Buying and Selling at AdaptHealth

In related news, Director Kenneth Samet acquired 23,500 shares of the stock in a transaction dated Thursday, August 6th. The stock was bought at an average cost of $6.38 per share, with a total value of $149,930.00. Following the purchase, the director directly owned 48,569 shares of the company’s stock, valued at approximately $309,870.22. This represents a 93.74% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.95% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

AHCO has been the subject of several analyst reports. Truist Financial cut their price target on AdaptHealth from $14.00 to $9.00 and set a “buy” rating for the company in a report on Wednesday, August 5th. Robert W. Baird dropped their target price on AdaptHealth from $10.00 to $9.00 and set an “outperform” rating for the company in a research note on Thursday, September 17th. Weiss Ratings reiterated a “sell (d)” rating on shares of AdaptHealth in a research report on Wednesday, August 19th. Canaccord Genuity Group set a $10.00 price target on AdaptHealth in a research note on Wednesday, August 5th. Finally, Royal Bank Of Canada lowered their price target on AdaptHealth from $15.00 to $8.00 and set an “outperform” rating for the company in a report on Thursday, August 6th. Seven equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $10.14.

About AdaptHealth

AdaptHealth Corp. (NASDAQ: AHCO) is a provider of home medical equipment, supplies and related healthcare services in the United States. The company helps patients manage chronic conditions and recover from illness or injury outside of traditional healthcare facilities, working with individuals, caregivers, physicians and payers.

Its products and services include respiratory equipment and supplies, oxygen therapy, sleep therapy devices such as continuous positive airway pressure systems, diabetes management products, mobility and accessibility equipment, and other durable medical equipment.